(Q59123145)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11557115%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Correlation of p53 oncoprotein expression with chemotherapy response in small cell lung carcinomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11557115%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

N Rodríguez-Salas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11557115%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J Palacios

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11557115%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

G Moreno

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11557115%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J de Castro

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11557115%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

M González-Barón

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11557115%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

C Gamallo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11557115%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 October 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11557115%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11557115%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11557115%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11557115%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

67-74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11557115%20AND%20SRC:MED&resulttype=core&format=json

P53, cell cycle control and apoptosis: Implications for cancer

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

p53: a frequent target for genetic abnormalities in lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Increased expression of mutant forms of p53 oncogene in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Histopathologic classification of small cell lung cancer. Changing concepts and terminology.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Survival in operable non-small-cell lung cancer: role of p53 mutations, tobacco smoking and asbestos exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

The meaning and use of the area under a receiver operating characteristic (ROC) curve

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

The fifty-year decline of cancer in America

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Small cell lung cancer: etiology, biology, clinical features, staging, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

DNA damage, p53 and anticancer therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

p21WAF1 and p53 immunohistochemical expression in breast carcinoma may predict therapeutic response to adjuvant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

p53 and treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: possible role of p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Immunohistochemical p53 protein status in nonsmall cell lung cancer is a promising indicator in determining in vitro chemosensitivity to some anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Tumor-suppressor p53: implications for tumor development and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900230-6

7 January 2021